Weiwen Zhu

Weiwen Zhu


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 September 2022 in Oral Diseases
Verified
Journal Article
Closed access
WZWeiwen Zhu
Weiwen Zhu
WSWeili Shen
Weili Shen
JWJie Wang
Jie Wang
YXYanbin Xu
Yanbin Xu
RZRundong Zhai
Rundong Zhai
Laikui LiuLaikui Liu
Laikui Liu

2 May 2024 in Cell Death Discovery
Verified
Journal Article
Open access
PDF file
RZRundong Zhai
Rundong Zhai
ZGZizhen Gong
Zizhen Gong
MWMengqi Wang
Mengqi Wang
ZNZihui Ni
Zihui Ni
JZJiayi Zhang
Jiayi Zhang
WZWeiwen Zhu
Weiwen Zhu
Neutrophil extracellular traps (NETs) are reticular structures composed of neutrophil elastase (NE), cathepsin G (CG) and DNA-histone enzyme complexes. Accumulating evidence has revealed that NETs play important roles in tumor progression, metastasis, and thrombosis. However, our understanding of its clinical value and mechanism of action in oral squamous cell carcinoma (OSCC) is limited and has not yet been systematically described. Here, we aimed to investigate the clinical significance of NETs in OSCC and the mechanisms by which they affect its invasive and metastatic capacity. Our results demonstrated that high enrichment of NETs is associated with poor prognosis in OSCC, and mechanistic studies have shown that NE in NETs promotes invasion and metastasis via NLRP3-mediated inhibition of pyroptosis in OSCC. These findings may provide a new therapeutic approach for OSCC.

9 August 2024 in Cancer Research
Verified
Journal Article
Closed access
PDF file
JZJiayi Zhang
Jiayi Zhang
ZNZihui Ni
Zihui Ni
YZYu Zhang
Yu Zhang
YGYan Guo
Yan Guo
RZRundong Zhai
Rundong Zhai
WZWeiwen Zhu
Weiwen Zhu
Tumor invasion and metastasis are the underlying causes of high mortality rate due to oral squamous cell carcinoma (OSCC). Energy metabolism reprogramming has been identified as a crucial process mediating tumor metastasis, thus indicating an urgent need for an in-depth investigation of the specific mechanisms of tumor energy metabolism. Here, we identified an RNA-binding protein, DAZ-associated protein 1 (DAZAP1), as a tumor-promoting factor with an important role in OSCC progression. DAZAP1 was significantly upregulated in OSCC, which enhanced the migration and invasion of OSCC cells and induced the epithelial–mesenchymal transition (EMT). RNA sequencing analysis and experimental validation demonstrated that DAZAP1 regulates mitochondrial energy metabolism in OSCC. Mechanistically, DAZAP1 underwent liquid–liquid phase separation to accumulate in the nucleus where it enhanced cytochrome c oxidase 16 (COX16) expression by regulating pre-mRNA alternative splicing, thereby promoting OSCC invasion and mitochondrial respiration. In mouse OSCC models, loss of DAZAP1 suppressed EMT, downregulated COX16, and reduced tumor growth and metastasis. In samples from patients with OSCC, expression of DAZAP1 positively correlated with COX16 and a high expression of both proteins was associated with poor patient prognosis. Together, these findings revealed a mechanism by which DAZAP1 supports mitochondrial metabolism and tumor development of OSCC, suggesting the potential of therapeutic strategies targeting DAZAP1 to block OSCC invasion and metastasis. Significance: The RNA-binding protein DAZAP1 undergoes phase separation to enhance COX16 expression and mediate metabolic reprogramming that enables tumor metastasis, highlighting DAZAP1 as a potential metabolic target for cancer therapy.

22 August 2022 in JCI Insight
Verified
Journal Article
Open access
PDF file
XSXin Shen
Xin Shen
WZWeiwen Zhu
Weiwen Zhu
PZPing Zhang
Ping Zhang
YFYu Fu
Yu Fu
JCJie Cheng
Jie Cheng
HJHongbing Jiang
Hongbing Jiang
Bisphosphonate-related (BP-related) osteonecrosis of the jaw (BRONJ) is one of the severe side effects of administration of BPs, such as zoledronic acid (ZA), which can disrupt the patient’s quality of life. Although the direct target of skeletal vasculature and bone resorption activity by BPs has been phenomenally observed, the underlying mechanism in BRONJ remains largely elusive. Thus, it is urgently necessary to discover effective therapeutic targets based on the multifaceted underlying mechanisms in the development of BRONJ. Here, we determined the inhibitory role of ZA-treated macrophages on osteoclast differentiation and type H vessel formation during tooth extraction socket (TES) healing. Mechanistically, ZA activated the NF-κB signaling pathway and then induced p65 nuclear translocation in macrophages to promote miR-149-5p transcription, resulting in impaired osteoclast differentiation via directly binding to the Traf6 3′-UTR region. Moreover, we identified that miR-149-5p–loaded extracellular vesicles derived from ZA-treated bone marrow–derived macrophages could regulate biological functions of endothelial cells via the Rap1a/Rap1b/VEGFR2 pathway. Furthermore, local administration of chemically modified antagomiR-149-5p was proven to be therapeutically effective in BRONJ mice. In conclusion, our findings illuminate the dual effects of miR-149-5p on skeletal angiogenesis and bone remolding, suggesting it as a promising preventive and therapeutic target for BRONJ.

11 September 2025 in Advanced Science
Verified
Journal Article
Open access
YZYu Zhang
Yu Zhang
BSBao Sun
Bao Sun
RZRong Zhou
Rong Zhou
ZGZizhen Gong
Zizhen Gong
YHYong Han
Yong Han
ZGZiyue Gu
Ziyue Gu
Cell cycle pathway, especially via cyclin D1‐CDK4/6 signaling, is enriched in immunotherapy‐resistant and immune‐excluded tumors. CDK4/6 inhibitor (CDK4/6i) induces antitumor immune phenotypes by targeting both tumor and immune cells, enhancing immune checkpoint blockade (ICB), but optimal combination modalities and the corresponding cellular mechanisms remain unclear. Here, it is shown that activation of tumor cell‐intrinsic cyclin D1‐CDK4/6 signaling is associated with low tumor‐infiltrating lymphocyte populations and immunotherapy resistance in head and neck squamous cell carcinoma (HNSCC). Comparison of sequential versus combinatorial regimens in subcutaneous or orthotopic HNSCC mice revealed that CDK4/6i priming before anti‐PD‐1 enhances response durability by promoting CD8 + and CD4 + T cell infiltration and decreasing overall neutrophil abundance. Mechanistically, IL15‐secreted Sell(hi) neutrophils induced Stat5a+ progenitor exhausted CD8 + T cells contributed to the antitumor effect of CDK4/6i priming modalities. Together with corroborating evidence from a clinically relevant patient‐derived‐organoid‐TIL (PDO‐TIL) co‐culture model, these findings support further clinical testing of brief CDK4/6i dosing before anti‐PD‐1 to improve ICB efficacy.

10 March 2026 in Clinical and Translational Medicine
Verified
Journal Article
Open access
MWMengyao Wang
Mengyao Wang
MWMengqi Wang
Mengqi Wang
ZGZizhen Gong
Zizhen Gong
FZFanrui Zeng
Fanrui Zeng
ZNZihui Ni
Zihui Ni
Laikui LiuLaikui Liu
Laikui Liu
Background: Throughout oral squamous cell carcinoma (OSCC) progression, tumor‐associated macrophages (TAMs) lose their antigen‐presenting capacity and anti‐tumor function. The mechanisms that cause this dysfunction are not fully understood. CD74 is essential for antigen‐presenting process, while little direct evidence describes its role in TAMs' immune function. Methods: We integrated single‐cell transcriptomic analysis, clinical cohort validation and CD74 conditional knockout mouse model to investigate the role of CD74 in TAMs during OSCC progression. Metabolomic analysis and mechanistic studies were performed to dissect how lactate‐mediated metabolic reprogramming regulates CD74 expression. Results: We demonstrate that lactate accumulation in TME induces metabolic reprogramming of TAMs, which drives the acetylation of C/EBPα, and consequently suppresses CD74 expression. This downregulation of CD74 impairs the antigen‐presenting capacity of TAMs, suppresses T cell activation, and ultimately promotes OSCC progression and recurrence. Conclusions: Our findings reveal the critical role of the lactate‐C/EBPα‐CD74 axis in shaping TAMs function, and provide potential therapeutic target for OSCC immunotherapy. Key points: CD74 hi TAMs decrease during OSCCprogression and are associated with patient prognosis. Loss of CD74 impairs antigen presentation andsuppresses T cell activation. Tumor‐derived lactateinhibits CD74 transcription via C/EBPα acetylation.